Prices are updated after-hours

Gilead Sciences, Inc.

GILD | $67.08 0.08% 0.06% 6.2M

(0.0% 1d) (-7.4% 1m) (-19.9% 1y) (0.0% 2d) (0.1% 3d) (0.5% 7d) (-100.0% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 83,519,779,851
http://www.gilead.com
Sec Filling | Patents | 11800 employees

(US) Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.

respiratory liver urea antiviral brands liver disease respiratory diseases

Drugs

Biktarvy (bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate)
Cayston (aztreonam)
COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)
DESCOVY (emtricitabine and tenofovir alafenamide)
Emtriva (EMTRICITABINE)
Epclusa (Velpatasvir and Sofosbuvir)
Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)
Hepsera (adefovir dipivoxil)
ODEFSEY (emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide)
Ranexa (RANOLAZINE)
Sovaldi (SOFOSBUVIR)
Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
Tybost (COBICISTAT)
Veklury (REMDESIVIR)
VEMLIDY (tenofovir alafenamide)
Viread (TENOFOVIR DISOPROXIL FUMARATE)
Vosevi (SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR)
Zydelig (idelalisib)

add to watch list Paper trade email alert is off

Lockheed Martin Corporation

LMT | $459.14 -0.2% -0.06% 830K

Electronic Technology

(0.0% 1d) (2.9% 1m) (-0.5% 1y) (0.0% 2d) (-0.2% 3d) (-1.0% 7d) (-43.06% volume)
Earnings Calendar: 2024-01-23
Market Cap: $ 110,165,199,436
http://www.lockheedmartin.com
Sec Filling | Patents | 110000 employees

Lockheed Martin Corp. operates as a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS) and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment provides air and missile defence systems; tactical missiles and air-to-ground precision strike weapon systems; logistics; fire control systems; mission operations support, readiness, engineering support and integration services; manned and unmanned ground vehicles; and energy management solutions. The RMS segment offers design, manufacture, service, and support for a variety of military and commercial helicopters; ship and submarine mission and combat systems; mission systems and sensors for rotary and fixed-wing aircraft; sea and land-based missile defence systems; radar systems; the Littoral Combat Ship; simulation and training services; and unmanned systems and technologies. The Space segment comprises of the research and development, design, engineering and production of satellites, strategic, and defensive missile systems and space transportation systems. The company was founded in 1961 and is headquartered in Bethesda, MD.

energy vehicles defense security satellite msa military sensor

add to watch list Paper trade email alert is off

LiveOne Inc

LVO | News | $1.88 8.05% 7.45% 290K

Information

(0.0% 1d) (-2.1% 1m) (51.6% 1y) (0.0% 2d) (7.4% 3d) (13.3% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 172,312,693
https://www.livexlive.com
Sec Filling | Patents | 76 employees

(US) Headquartered in Los Angeles, California, LiveXLive Media, Inc. (pronounced Live 'by' Live) is a leading global all-in-one streaming artist-first platform delivering premium music and entertainment content and live-streams from the world's top artists, expertly curated streaming radio stations, podcasts, and original video and audio-on-demand content, as well as personalized merchandise, connecting artists to millions of fans every day. The Company has streamed over 1,800 artists since January 2020 and has created a valuable connection between bands, fans, and brands by building long-term franchises in audio, video, podcasting, pay-per-view (PPV), live-streaming, and specialty merchandise. LiveXLive is available on iOS, Android, Roku, Apple TV, and Amazon Fire, and through OTT, Samsung TV, STIRR, Sling, and XUMO, in addition to its own app, online website, and social channels. The Company's wholly-owned subsidiary PodcastOne, generates more than 2.25 billion downloads per year with 400+ episodes distributed per week across a stable of hundreds of top podcasts. The Company's other major wholly-owned subsidiaries are LiveXLive, Slacker Radio, React Presents, and Custom Personalization Solutions.

brands

add to watch list Paper trade email alert is off

Laboratory Corporation of America Holdings

LH 4 | $207.94 -0.01% -3.33% 790K

Health Services

(0.0% 1d) (-3.4% 1m) (-6.9% 1y) (0.0% 2d) (1.1% 3d) (2.4% 7d) (NaN% volume)
Earnings Calendar: 2024-02-15
Market Cap: $ 17,493,136,527
http://www.labcorp.com
Sec Filling | Patents | 65000 employees

(US) Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

genomic diagnostics

add to watch list Paper trade email alert is off

First Bank

FRBA | News | $11.97 -2.84% -3.36% 62K

Finance

(0.0% 1d) (-8.3% 1m) (23.8% 1y) (0.0% 2d) (-2.8% 3d) (-1.2% 7d) (57.57% volume)
Earnings Calendar: 2024-01-24
Market Cap: $ 234,244,928
http://www.firstbanknj.com
Sec Filling | Patents | 199 employees

(United States) First Bank is a state-chartered commercial bank, which offers a traditional range of deposit and loan products to individuals and businesses in its Central and Southern New Jersey markets. Its primary focus within community banking encompasses the company's primary business which includes providing a wide range of commercial and retail and related banking services. The company was founded on April 23, 2007 and is headquartered in Hamilton, NJ.

add to watch list Paper trade email alert is off

Astrazeneca PLC

AZN | News | $71.2 0.49% 0.46% 5.4M

Health Technology

(0.0% 1d) (7.3% 1m) (-3.3% 1y) (0.0% 2d) (1.1% 3d) (3.9% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 220,751,511,411
http://astrazeneca.com
Sec Filling | Patents | 70600 employees

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

cardiovascular respiratory urea renal metabolic

add to watch list Paper trade email alert is off

Becton, Dickinson and Company

BDX | $233.83 -0.23% 0.0% 780K

Health Technology

(0.0% 1d) (-3.3% 1m) (-9.5% 1y) (0.0% 2d) (-0.2% 3d) (-0.1% 7d) (-2.58% volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 67,553,954,660
http://www.bd.com
Sec Filling | Patents | 72000 employees

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

cancer infectious disease diagnostics injection